First Trust Nasdaq Pharmaceuticals ETF
FTXH$33.79 -0.17 (-0.50%)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 31, 2025 | $0.13 | 2025-12-12 | 2025-12-12 |
| September 30, 2025 | $0.15 | 2025-09-25 | 2025-09-25 |
| June 30, 2025 | $0.09 | 2025-06-26 | 2025-06-26 |
| March 31, 2025 | $0.10 | 2025-03-27 | 2025-03-27 |
| December 31, 2024 | $0.13 | 2024-12-13 | 2024-12-13 |
Dividends Summary
- Consistent Payer: First Trust Nasdaq Pharmaceuticals ETF has rewarded shareholders with 38 dividend payments over the past 9 years.
- Total Returned Value: Investors who held FTXH shares during this period received a total of $2.95 per share in dividend income.
- Latest Payout: The most recent dividend of $0.13/share was paid 23 days ago, on December 31, 2025.
- Yield & Schedule: FTXH currently pays dividends quarterly with an annual yield of 1.37%.
- Dividend Growth: Since 2016, the dividend payout has grown by 2210.7%, from $0.01 to $0.13.
Company News
A Look at Pharma ETFs Post Q1 Earnings
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus
Johnson & Johnson (JNJ) continued with its long streak of earnings beat but lagged revenue estimates.
A Look at Pharma ETFs After Q4 Earnings
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. However, many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
Pharma ETFs in Focus Post Q3 Earnings
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
